Potential new mRNA-based therapy for pre-eclampsia

Lipid nanoparticles targeting VEGF mRNA show promise in treating pre-eclampsia, restoring maternal blood pressure and enhancing fetal health in murine models.

Novavax vaccine shows resilient defense against symptomatic COVID-19 despite Omicron challenge

Recent study assesses NVX-CoV2373 vaccine’s effectiveness against Omicron variant. Findings show decreased efficacy over four months, but stable protection against symptomatic COVID-19.

October 9, 2023

FDA offers positive signals for potential pediatric neuroblastoma drug ahead of ODAC meeting

The FDA’s Oncologic Drugs Advisory Committee tomorrow will review US WorldMeds’ potential high-risk pediatric neuroblastoma drug to reduce the risk of relapse after front-line therapy.

October 4, 2023

The painful pandemic lessons Mandy Cohen carries to the CDC

As covid-19 devastated communities across the nation in spring 2020, a group of Black ministers in this racially divided city made an urgent plea for

August 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.